Two-week intensive outpatient trauma program for PTSD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with PTSD will receive an outpatient intensive treatment over two weeks combining Prolonged Exposure and EMDR. Up to 42 patients will complete validated self-report measures of PTSD symptoms (PCL-5, ITQ) and quality of life/functioning (WHO-5, WSAS) at baseline, one week, and twelve weeks after treatment. In-depth qualitative interviews with up to 30 participants—focusing on people with minority backgrounds, males, and those with limited benefit—will explore outcomes and needs for adjustment. The study uses a mixed-methods design to combine quantitative symptom change data with qualitative feedback on feasibility and patient experience.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* PTSD
* 18-65 years
* Able to give written informed consent.

Exclusion Criteria:

* Active substance abuse
* psychotic or bipolar disorder
* organic brain disorder
* IQ\< 70
* Currently in a life-threating situation.
* Serious suicide risk.

Where it's running

• Oslo University Hospital
  Oslo, Norway Recruiting

Study contacts

• Principal investigator: Julie H Evensen, MD PhD — Oslo University Hospital
• Study coordinator: Julie H Evensen, MD PhD
• Email: uxevej@ous-hf.no
• Phone: 004799339292

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Deep Brain Reorienting for PTSD in Veterans

  This study tests whether Deep Brain Reorienting can help reduce PTSD symptoms in military veterans compared with usual care.

  Recruiting University of Alberta · Edmonton, Alberta · NCT07840417

• Trauma recovery options for veterans: comparing HRV biofeedback and present-centered therapy

  This trial tests whether Heart Rate Variability Biofeedback plus trauma-informed care helps veterans with PTSD and substance use issues more than present-centered therapy.

  Recruiting Phase 2/3 Coatesville VA Medical Center · Coatesville, Pennsylvania · NCT07756723

• CIDI 5.0 validation against SCID-5 for lifetime mental disorders in Hong Kong adults

  This study tests whether the CIDI 5.0 interview can reliably identify lifetime mental disorders in adults in Hong Kong by comparing it with the SCID-5 diagnostic interview.

  Recruiting The University of Hong Kong · Hong Kong · NCT07604753

• Side-by-Side Testing of SPARCS and the Unified Protocol for Youth with Chronic Illness and Trauma

  This trial tests whether two trauma-focused therapies (SPARCS and the Unified Protocol) help kids and teens with chronic medical conditions feel less trauma-related distress and function better, delivered in group or individual formats.

  Recruiting Ann & Robert H Lurie Children's Hospital of Chicago · Chicago, Illinois · NCT07483333

• Metacognitive Therapy vs Cognitive-Behavioral Therapy for Anxiety Disorders

  This study asks people with generalized anxiety disorder, social anxiety disorder, or PTSD to share their experiences after trying metacognitive therapy or disorder-specific cognitive-behavioral therapy in a randomized trial.

  Recruiting Karolinska Institutet · Stockholm · NCT07382323

• Single-dose ayahuasca versus esketamine for PTSD

  This study will try a single dose of ayahuasca or esketamine to see if it quickly reduces symptoms in adults with PTSD.

  Recruiting Phase 2 University of Sao Paulo · Ribeirão Preto, São Paulo · NCT07317206

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.